Stay updated on Pembrolizumab for Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.

Latest updates to the Pembrolizumab for Mesothelioma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision history now includes a new version labeled v3.5.4. The previous version v3.5.3 is removed, indicating an update to the page's revision metadata.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page’s revision/version identifier updates from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a change to the website’s software version without altering the study record information.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded 'Results Submission Events (1)' and 'Revision: v3.5.2'; removed 'Revision: v3.5.0' from the history.SummaryDifference0.3%

- Check59 days agoChange DetectedAddition of 'Results Submitted' and removal of 'No Results Posted' are reflected in the study record history.SummaryDifference0.1%

- Check74 days agoChange DetectedFooter revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision entry labeled v3.4.3 has been added to the Record History, and the previous v3.4.2 entry has been removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.